Status:
NOT_YET_RECRUITING
Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
Lancardis Foundation
Conditions:
Cancer (With or Without Metastasis)
COPD III/IV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Persistent dyspnea is a debilitating symptom, that is common and difficult to treat. This symptom is found in many different diseases including chronic obstructive pulmonary disease (COPD), interstiti...
Detailed Description
Hypnosis is currently used to reduce anxiety in patients with breathlessness. Although a reduction in anxiety has been correlated with a reduction in dyspnea, the effectiveness of hypnosis on breathle...
Eligibility Criteria
Inclusion
- Patients aged ≥ 18 years and
- Primary diagnosis of metastatic cancer, COPD stage at least 3B or E, ILD, or CHF and
- Dyspnea stage NYHA III-IV or mMRC 3-4
Exclusion
- Have had hypnosis treatment in the last 12 months
- Have an estimated life expectancy of less than 6 months
- Have participated in pulmonary rehabilitation in the last 6 months
- Have been hospitalised in the last month (30 days)
- Are unable to come to the hospital for 3 outpatient consultations (1 every two weeks)
- Have a condition that would interfere with their ability to respond to the questionnaires (i.e. cognitive impairment, hearing impairment, etc.)
- Are not eligible for a hypnosis session due to a psychiatric disorder
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT07173348
Start Date
October 1 2025
End Date
October 1 2027
Last Update
September 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland, 1211
2
Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland, 1211